Focal Adhesion Kinase and P53 Synergistically Decrease Neuroblastoma Cell Survival

Overview

Journal J Surg Res

Specialty General Surgery

Date 2015 Apr 12

PMID 25862488

Citations 16

Authors

Lauren A Gillory

Jerry E Stewart

Michael L Megison

Alicia M Waters

Elizabeth A Beierle

Affiliations

Soon will be listed here.

Abstract

Neuroblastoma is the most common extracranial solid tumor of childhood and is responsible for over 15% of pediatric cancer deaths. Focal adhesion kinase (FAK) is a nonreceptor tyrosine kinase that is important in many facets of neuroblastoma tumor development and progression. The p53 oncogene, although wild type in most neuroblastomas, lacks significant function as a tumor suppressor in these tumors. Recent reports have found that FAK and p53 interact in some tumor types. We have hypothesized FAK and p53 coordinately control each other's expression and also interact in neuroblastoma. In the present study, we showed that not only do FAK and p53 interact but each one controls the expression of the other. In addition, we also examined the effects of FAK inhibition combined with p53 activation in neuroblastoma and showed that these two, in combination, had a synergistic effect on neuroblastoma cell survival. The findings from this present study help to further our understanding of the regulation of neuroblastoma tumorigenesis and may provide novel therapeutic strategies and targets for neuroblastoma and other pediatric solid tumors.

Citing Articles

Hypoxia regulates adipose mesenchymal stem cells proliferation, migration, and nucleus pulposus-like differentiation by regulating endoplasmic reticulum stress via the HIF-1α pathway.

Wu J, Yu L, Liu Y, Xiao B, Ye X, Zhao H J Orthop Surg Res. 2023; 18(1):339.

PMID: 37158945 PMC: 10169485. DOI: 10.1186/s13018-023-03818-1.

The Extracellular Matrix and Neuroblastoma Cell Communication-A Complex Interplay and Its Therapeutic Implications.

Horwacik I Cells. 2022; 11(19).

PMID: 36231134 PMC: 9564247. DOI: 10.3390/cells11193172.

New Insights on the Nuclear Functions and Targeting of FAK in Cancer.

Pomella S, Cassandri M, Braghini M, Marampon F, Alisi A, Rota R Int J Mol Sci. 2022; 23(4).

PMID: 35216114 PMC: 8874710. DOI: 10.3390/ijms23041998.

Insight into Hypoxia Stemness Control.

Di Mattia M, Mauro A, Citeroni M, Dufrusine B, Peserico A, Russo V Cells. 2021; 10(8).

PMID: 34440930 PMC: 8394199. DOI: 10.3390/cells10082161.

EZH2 inhibition decreases neuroblastoma proliferation and in vivo tumor growth.

Bownes L, Williams A, Marayati R, Stafman L, Markert H, Quinn C PLoS One. 2021; 16(3):e0246244.

PMID: 33690617 PMC: 7942994. DOI: 10.1371/journal.pone.0246244.

References

Brodeur G, Seeger R, Schwab M, Varmus H, Bishop J . Amplification of N-myc in untreated human neuroblastomas correlates with advanced disease stage. Science. 1984; 224(4653):1121-4. DOI: 10.1126/science.6719137. View

Smith C, Golubovskaya V, Peck E, Xu L, Monia B, Yang X . Effect of focal adhesion kinase (FAK) downregulation with FAK antisense oligonucleotides and 5-fluorouracil on the viability of melanoma cell lines. Melanoma Res. 2005; 15(5):357-62. DOI: 10.1097/00008390-200510000-00003. View

Cotterill S, Parker L, More L, Craft A . Neuroblastoma: changing incidence and survival in young people aged 0-24 years. A report from the North of England Young Persons' Malignant Disease Registry. Med Pediatr Oncol. 2001; 36(1):231-4. DOI: 10.1002/1096-911X(20010101)36:1<231::AID-MPO1056>3.0.CO;2-U. View

Suh H, Choi K, Lee C . CR389, a benzoimidazolyl pyridinone analog, induces cell cycle arrest and apoptosis via p53 activation in human ovarian cancer PA-1 cells. J Microbiol Biotechnol. 2015; 25(3):418-22. DOI: 10.4014/jmb.1412.12080. View

Tweddle D, Malcolm A, Cole M, Pearson A, Lunec J . p53 cellular localization and function in neuroblastoma: evidence for defective G(1) arrest despite WAF1 induction in MYCN-amplified cells. Am J Pathol. 2001; 158(6):2067-77. PMC: 1892004. DOI: 10.1016/S0002-9440(10)64678-0. View

Megison M, Stewart J, Nabers H, Gillory L, Beierle E . FAK inhibition decreases cell invasion, migration and metastasis in MYCN amplified neuroblastoma. Clin Exp Metastasis. 2012; 30(5):555-68. PMC: 3625446. DOI: 10.1007/s10585-012-9560-7. View

Xenaki D, Eden T, Hickman J, Chresta C . MDM2 mediated nuclear exclusion of p53 attenuates etoposide-induced apoptosis in neuroblastoma cells. Mol Pharmacol. 2000; 59(1):135-43. DOI: 10.1124/mol.59.1.135. View

Lim S, Chen X, Lim Y, Hanson D, Vo T, Howerton K . Nuclear FAK promotes cell proliferation and survival through FERM-enhanced p53 degradation. Mol Cell. 2008; 29(1):9-22. PMC: 2234035. DOI: 10.1016/j.molcel.2007.11.031. View

Chou T . Drug combination studies and their synergy quantification using the Chou-Talalay method. Cancer Res. 2010; 70(2):440-6. DOI: 10.1158/0008-5472.CAN-09-1947. View

10.

Golubovskaya V, Ho B, Zheng M, Magis A, Ostrov D, Morrison C . Disruption of focal adhesion kinase and p53 interaction with small molecule compound R2 reactivated p53 and blocked tumor growth. BMC Cancer. 2013; 13:342. PMC: 3712010. DOI: 10.1186/1471-2407-13-342. View

11.

Golubovskaya V, Zheng M, Zhang L, Li J, Cance W . The direct effect of focal adhesion kinase (FAK), dominant-negative FAK, FAK-CD and FAK siRNA on gene expression and human MCF-7 breast cancer cell tumorigenesis. BMC Cancer. 2009; 9:280. PMC: 3087335. DOI: 10.1186/1471-2407-9-280. View

12.

Kornberg L . Ad-fRNK and Ad-p53 cooperate to augment drug-induced death of a transformed cell line. Anticancer Res. 2006; 26(4B):3025-31. View

13.

Manders E, Verbeek F, Aten J . Measurement of co-localization of objects in dual-colour confocal images. J Microsc. 2021; 169(3):375-382. DOI: 10.1111/j.1365-2818.1993.tb03313.x. View

14.

Kweh F, Zheng M, Kurenova E, Wallace M, Golubovskaya V, Cance W . Neurofibromin physically interacts with the N-terminal domain of focal adhesion kinase. Mol Carcinog. 2009; 48(11):1005-17. PMC: 2783617. DOI: 10.1002/mc.20552. View

15.

He J, Gu L, Zhang H, Zhou M . Crosstalk between MYCN and MDM2-p53 signal pathways regulates tumor cell growth and apoptosis in neuroblastoma. Cell Cycle. 2011; 10(17):2994-3002. PMC: 3218600. DOI: 10.4161/cc.10.17.17118. View

16.

Komarov P, Komarova E, Kondratov R, Coon J, Chernov M, Gudkov A . A chemical inhibitor of p53 that protects mice from the side effects of cancer therapy. Science. 1999; 285(5434):1733-7. DOI: 10.1126/science.285.5434.1733. View

17.

Halder J, Lin Y, Merritt W, Spannuth W, Nick A, Honda T . Therapeutic efficacy of a novel focal adhesion kinase inhibitor TAE226 in ovarian carcinoma. Cancer Res. 2007; 67(22):10976-83. DOI: 10.1158/0008-5472.CAN-07-2667. View

18.

Beierle E, Ma X, Trujillo A, Kurenova E, Cance W, Golubovskaya V . Inhibition of focal adhesion kinase and src increases detachment and apoptosis in human neuroblastoma cell lines. Mol Carcinog. 2009; 49(3):224-34. PMC: 2849163. DOI: 10.1002/mc.20592. View

19.

Zhu X, Wimmer K, Kuick R, Lamb B, Motyka S, Jasty R . N-myc modulates expression of p73 in neuroblastoma. Neoplasia. 2002; 4(5):432-9. PMC: 1564122. DOI: 10.1038/sj.neo.7900255. View

20.

Stewart J, Ma X, Megison M, Nabers H, Cance W, Kurenova E . Inhibition of FAK and VEGFR-3 binding decreases tumorigenicity in neuroblastoma. Mol Carcinog. 2013; 54(1):9-23. PMC: 4370318. DOI: 10.1002/mc.22070. View